These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18611005)

  • 1. Magnetic nanoparticle-peptide conjugates for in vitro and in vivo targeting and extraction of cancer cells.
    Scarberry KE; Dickerson EB; McDonald JF; Zhang ZJ
    J Am Chem Soc; 2008 Aug; 130(31):10258-62. PubMed ID: 18611005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted removal of migratory tumor cells by functionalized magnetic nanoparticles impedes metastasis and tumor progression.
    Scarberry KE; Mezencev R; McDonald JF
    Nanomedicine (Lond); 2011 Jan; 6(1):69-78. PubMed ID: 21182419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermoresponsive core-shell magnetic nanoparticles for combined modalities of cancer therapy.
    Purushotham S; Chang PE; Rumpel H; Kee IH; Ng RT; Chow PK; Tan CK; Ramanujan RV
    Nanotechnology; 2009 Jul; 20(30):305101. PubMed ID: 19581698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface-functionalized ultrasmall superparamagnetic nanoparticles as magnetic delivery vectors for camptothecin.
    Cengelli F; Grzyb JA; Montoro A; Hofmann H; Hanessian S; Juillerat-Jeanneret L
    ChemMedChem; 2009 Jun; 4(6):988-97. PubMed ID: 19347834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the urokinase plasminogen activator receptor with synthetic self-assembly nanoparticles.
    Wang M; Löwik DW; Miller AD; Thanou M
    Bioconjug Chem; 2009 Jan; 20(1):32-40. PubMed ID: 19099499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting to carcinoma cells with chitosan- and starch-coated magnetic nanoparticles for magnetic hyperthermia.
    Kim DH; Kim KN; Kim KM; Lee YK
    J Biomed Mater Res A; 2009 Jan; 88(1):1-11. PubMed ID: 18257079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetorelaxometric quantification of magnetic nanoparticles in an artery model after ex vivo magnetic drug targeting.
    Richter H; Wiekhorst F; Schwarz K; Lyer S; Tietze R; Alexiou Ch; Trahms L
    Phys Med Biol; 2009 Sep; 54(18):N417-24. PubMed ID: 19700820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicle-stimulating hormone peptide can facilitate paclitaxel nanoparticles to target ovarian carcinoma in vivo.
    Zhang XY; Chen J; Zheng YF; Gao XL; Kang Y; Liu JC; Cheng MJ; Sun H; Xu CJ
    Cancer Res; 2009 Aug; 69(16):6506-14. PubMed ID: 19638590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immobilization of homing peptide on magnetite nanoparticles and its specificity in vitro.
    Gan ZF; Jiang JS; Yang Y; Du B; Qian M; Zhang P
    J Biomed Mater Res A; 2008 Jan; 84(1):10-8. PubMed ID: 17600321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Destruction of breast cancers and their metastases by lytic peptide conjugates in vitro and in vivo.
    Hansel W; Enright F; Leuschner C
    Mol Cell Endocrinol; 2007 Jan; 260-262():183-9. PubMed ID: 17101210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TMTP1, a novel tumor-homing peptide specifically targeting metastasis.
    Yang W; Luo D; Wang S; Wang R; Chen R; Liu Y; Zhu T; Ma X; Liu R; Xu G; Meng L; Lu Y; Zhou J; Ma D
    Clin Cancer Res; 2008 Sep; 14(17):5494-502. PubMed ID: 18765541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective removal of ovarian cancer cells from human ascites fluid using magnetic nanoparticles.
    Scarberry KE; Dickerson EB; Zhang ZJ; Benigno BB; McDonald JF
    Nanomedicine; 2010 Jun; 6(3):399-408. PubMed ID: 19969103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptides and metallic nanoparticles for biomedical applications.
    Kogan MJ; Olmedo I; Hosta L; Guerrero AR; Cruz LJ; Albericio F
    Nanomedicine (Lond); 2007 Jun; 2(3):287-306. PubMed ID: 17716175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticles.
    Liu Y; Franzen S
    Bioconjug Chem; 2008 May; 19(5):1009-16. PubMed ID: 18393455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic separation of melanoma-specific cytotoxic T lymphocytes from a vaccinated melanoma patient's blood using MHC/peptide complex-conjugated bacterial magnetic particles.
    Takahashi M; Akiyama Y; Ikezumi J; Nagata T; Yoshino T; Iizuka A; Yamaguchi K; Matsunaga T
    Bioconjug Chem; 2009 Feb; 20(2):304-9. PubMed ID: 19143499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A specific drug targeting system based on polyhydroxyalkanoate granule binding protein PhaP fused with targeted cell ligands.
    Yao YC; Zhan XY; Zhang J; Zou XH; Wang ZH; Xiong YC; Chen J; Chen GQ
    Biomaterials; 2008 Dec; 29(36):4823-30. PubMed ID: 18824258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting CD24 for treatment of ovarian cancer by short hairpin RNA.
    Su D; Deng H; Zhao X; Zhang X; Chen L; Chen X; Li Z; Bai Y; Wang Y; Zhong Q; Yi T; Qian Z; Wei Y
    Cytotherapy; 2009; 11(5):642-52. PubMed ID: 19593703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid targeting of protein conjugates into ascites tumour cells from ovarian cancer patients.
    Ward CM; Acheson N; Seymour LW
    J Drug Target; 2000; 8(2):119-23. PubMed ID: 10852343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic chitosan nanoparticles as a drug delivery system for targeting photodynamic therapy.
    Sun Y; Chen ZL; Yang XX; Huang P; Zhou XP; Du XX
    Nanotechnology; 2009 Apr; 20(13):135102. PubMed ID: 19420486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of magnetite nanoparticles for implant-assisted magnetic drug targeting in thrombolytic therapy.
    Kempe M; Kempe H; Snowball I; Wallén R; Arza CR; Götberg M; Olsson T
    Biomaterials; 2010 Dec; 31(36):9499-510. PubMed ID: 20732712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.